Making The Business Of Drug Adherence An Easier Pill To Swallow
This article was originally published in Start Up
Medication adherence is a big problem, and recent studies are bringing the actual costs and causes into sharper focus. At the same time, health care reforms such as electronic health records and prescriptions, as well as new incentives from the US government, have encouraged investors to tackle solutions to the problem. Questions remain about the impact of these reforms, but the companies profiled in this issue, HealthPrize Technologies, PillJogger, RxAnte and SentiCare, see an evolving climate in which their medication adherence technology solutions can turn into profitable businesses.
You may also be interested in...
Researchers at Harvard and Express Scripts estimate that improved adherence to diabetes drugs could save nearly $5 billion annually across the U.S. health care system.
On the heels of FDA clearance for the firm's ingestible sensor technology, Proteus Digital Health Chief Medical Officer George Savage talks to “The Gray Sheet.”
The first tool that will be developed is an interactive web application designed to help primary care clinicians assess and engage patients at risk for cardiometabolic syndrome.